Evidence map›Paper›PMID 31628022›Full record

ArticleEBioMedicine2019

Detection of HIV transmission hotspots in British Columbia, Canada: A novel framework for the prioritization and allocation of treatment and prevention resources.

Angela McLaughlin, Paul Sereda, Natalia Oliveira, Rolando Barrios, Chanson J Brumme, Zabrina L Brumme, Julio S G Montaner, Jeffrey B Joy

Abstract read
In one paragraph

Article in EBioMedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. HIV Care Prioritization Using Phylogenetic Branch Length.Journal of acquired immune deficiency syndromes (1999) · 2021
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angela McLaughlinBritish Columbia Centre for Excellence in HIV/AIDS, University of British Columbia Department of Medicine, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada; Bioinformatics, University of British Columbia, Vancouver, BC, Canada.
Paul SeredaBritish Columbia Centre for Excellence in HIV/AIDS, University of British Columbia Department of Medicine, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
Natalia OliveiraBritish Columbia Centre for Excellence in HIV/AIDS, University of British Columbia Department of Medicine, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
Rolando BarriosBritish Columbia Centre for Excellence in HIV/AIDS, University of British Columbia Department of Medicine, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Chanson J BrummeBritish Columbia Centre for Excellence in HIV/AIDS, University of British Columbia Department of Medicine, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
Zabrina L BrummeBritish Columbia Centre for Excellence in HIV/AIDS, University of British Columbia Department of Medicine, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Julio S G MontanerBritish Columbia Centre for Excellence in HIV/AIDS, University of British Columbia Department of Medicine, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada; Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Jeffrey B JoyBritish Columbia Centre for Excellence in HIV/AIDS, University of British Columbia Department of Medicine, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada; Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: jjoy@cfenet.ubc.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentifying populations at high risk of HIV transmission is critical for prioritizing treatment and prevention resources and achieving the UNAIDS 90-90-90 Targets.

methodsHIV transmission rates can be estimated from phylogenetic trees as viral lineage-level diversification rates. To identify HIV-1 transmission foci in British Columbia, Canada, we inferred diversification rates from phylogenetic trees of 36 271 HIV-1 sequences from 9630 anonymized individuals. Diversification rates were combined with sociodemographic and clinical data, then aggregated by patients' area of residence to predict the distribution of new HIV cases between 2008 and 2018. The predictive power of the model was compared with a phylogenetically uninformed model.

findingsAggregated diversification rate measures were predictive of new HIV cases in the subsequent year after adjusting for prevalent and incident cases in the previous year. For every one-unit increase in the mean of the top five diversification rates, the number of new HIV cases increased by on average 1·38-fold (95% CI, 1·28-1·49). In a blind prediction of 2018 cases, diversification rate improved the model's specificity by 12%, accuracy by 9%, top 20 agreement by 100%, and correlation of predicted and observed values by 162% relative to a model that incorporated epidemiological data alone.

interpretationBy predicting the distribution of future HIV cases, a combined phylogenetic and epidemiological approach identifies hotspots where public health resources are needed most.

fundingCanadian Institutes of Health Research, University of British Columbia, Public Health Agency of Canada, Genome Canada, Genome BC, Michael Smith Foundation for Health Research, and BC Centre for Excellence in HIV/AIDS.

Indexed as

HIV-1AdultBritish ColumbiaFemaleGenotypeHealth ResourcesHIV InfectionsHumansMaleMiddle AgedPrevalenceResource AllocationYoung AdultEpidemiologyHIVPhylogeneticsPredictive modelTransmission

Identifiers

PMID31628022
PMCPMC6838403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.